Patents Assigned to HydraDx, Inc.
-
Publication number: 20150216471Abstract: Detection of one or more fronts of saliva advancing simultaneously in multiple directions may be used to determine salivary secretion rate, as may be indicative of state of euhydration or dehydration. An array of electrical contacts may be arranged between a substrate and a liquid collection element, and used to detect saliva migrating through the liquid collection element. A substrate may include a leading edge defining a notch or recess to receive a sublingual frenulum for positioning a liquid collection element proximate to a sublingual salivary duct, or may include a flexible substrate for positioning a liquid collection element in an oral cavity proximate to at least one parotid or minor salivary duct. Sensing of salivary flow rate may be augmented by measuring concentration of at least one analyte in saliva and/or sensing various environmental factors. Groups of electrical contacts may be arranged proximate to different salivary glands or ducts.Type: ApplicationFiled: August 15, 2013Publication date: August 6, 2015Applicant: HYDRADX INC.Inventors: Andrew S. Goldstein, Kirk Charles Harmon
-
Patent number: 8611992Abstract: Timed sensing of collection of saliva in a liquid collection element of predetermined volumetric capacity may be used to determine salivary secretion rate, as may be indicative of state of euhydration or dehydration. Sensing of salivary flow rate may be further augmented by sensing concentration of at least one analyte in saliva (e.g., with an immunochromatographic assay performed in a lateral flow device) in order to determine a state of euhydration or dehydration. Production of saliva may be stimulated, and collected saliva may be analyzed to generate an analyte detection signal that indicative of presence and/or correlative of concentration of at least one analyte in the collected saliva to sense a state of euhydration or dehydration.Type: GrantFiled: July 3, 2012Date of Patent: December 17, 2013Assignee: HydraDx, Inc.Inventors: Andrew S. Goldstein, Frank Bellizzi
-
Patent number: 8326412Abstract: Timed sensing of collection of saliva in a liquid collection element of predetermined volumetric capacity may be used to determine salivary secretion rate, as may be indicative of state of euhydration or dehydration. Sensing of salivary flow rate may be further augmented by sensing concentration of at least one analyte in saliva (e.g., with an immunochromatographic assay performed in a lateral flow device) in order to determine a state of euhydration or dehydration. Production of saliva may be stimulated, and collected saliva may be analyzed to generate an analyte detection signal that indicative of presence and/or correlative of concentration of at least one analyte in the collected saliva to sense a state of euhydration or dehydration.Type: GrantFiled: September 30, 2011Date of Patent: December 4, 2012Assignee: HydraDx, Inc.Inventors: Andrew S. Goldstein, Frank Bellizzi
-
Publication number: 20120289863Abstract: Timed sensing of collection of saliva in a liquid collection element of predetermined volumetric capacity may be used to determine salivary secretion rate, as may be indicative of state of euhydration or dehydration. Sensing of salivary flow rate may be further augmented by sensing concentration of at least one analyte in saliva (e.g., with an immunochromatographic assay performed in a lateral flow device) in order to determine a state of euhydration or dehydration. Production of saliva may be stimulated, and collected saliva may be analyzed to generate an analyte detection signal that indicative of presence and/or correlative of concentration of at least one analyte in the collected saliva to sense a state of euhydration or dehydration.Type: ApplicationFiled: July 3, 2012Publication date: November 15, 2012Applicant: HYDRADX, INC.Inventors: Andrew S. Goldstein, Frank Bellizzi
-
Publication number: 20120083711Abstract: Timed sensing of collection of saliva in a liquid collection element of predetermined volumetric capacity may be used to determine salivary secretion rate, as may be indicative of state of euhydration or dehydration. Sensing of salivary flow rate may be further augmented by sensing concentration of at least one analyte in saliva (e.g., with an immunochromatographic assay performed in a lateral flow device) in order to determine a state of euhydration or dehydration. Production of saliva may be stimulated, and collected saliva may be analyzed to generate an analyte detection signal that indicative of presence and/or correlative of concentration of at least one analyte in the collected saliva to sense a state of euhydration or dehydration.Type: ApplicationFiled: September 30, 2011Publication date: April 5, 2012Applicant: HYDRADX, INC.Inventors: Andrew S. Goldstein, Frank Bellizzi
-
Publication number: 20110287409Abstract: Diagnostic devices and methods involve comparison of relative levels of first and second components and/or characteristics of a fluid sample (e.g., saliva), preferably using bound antibodies arranged to interact with selected components, and colorimetric indicators that are released in proportion to relative concentration or amount of the components or characteristics, as indicative of a health condition such as dehydration state, shock state, stress state, disease state, drug consumption, and drug metabolization. Amylase and IgA may be selected as specific salivary components of interest.Type: ApplicationFiled: January 17, 2010Publication date: November 24, 2011Applicant: HYDRADX, INC.Inventor: Stephen D. O'Connor
-
Publication number: 20100330684Abstract: Diagnostic devices and methods involve comparison of relative levels of first and second components and/or characteristics of a fluid sample (e.g., saliva), preferably using antibodies arranged to interact with selected components, and colorimetric indicators that are bound or released in proportion to relative concentration or amount of the components or characteristics, as indicative of a health condition such as dehydration state, shock state, stress state, disease state, drug consumption, and drug metabolization. Amylase and IgA may be selected as specific salivary components of interest.Type: ApplicationFiled: September 13, 2010Publication date: December 30, 2010Applicant: HydraDX, Inc.Inventor: Stephen D. O'Connor